Back to main Research Day page
Time | Topic | Speaker |
---|---|---|
8:30 am |
Welcome | Douglas D. Richman, MD |
Session 1: Basic and Translational Science, moderated by Mary Lewinski, MD, PhD | ||
8:40 am |
Plasma (1->3)-Beta-D-glucan levels correlate with neurocognitive impairment in HIV |
Martin Hoenigl, MD |
9:00 am |
Seroprevalence of Chikungunya virus among people living with HIV/AIDS in Braz |
Raphael de Souza Borges |
9:20 am |
Combined EM-proteomics approach to study HIV-1 Vpu-host interactions |
Charlotte Stoneham, PhD |
9:40 am |
Early transcriptional response of HIV to SAHA is driven by naïve CD4 T cell subset |
Nadejda Beliakova-Bethell, PhD |
Session 2: Clinical Research, moderated by Maile Karris, MD | ||
10:20 am |
Using clinical natural language processing to extract morphine milligram equivalents (MME) from EHR prescriptions |
Lucas Hill, PharmD |
10:40 am |
Factors associated with mortality in patients admitted with severe sepsis in Maputo Central Hospital |
Lucia Chambal, MD |
11:00 am |
Monitoring tuberculosis treatment using Video Observed Therapy among people with HIV in Tijuana, Mexico |
Richard Garfein, PhD, MPH |
11:20 am |
Emerging Investigator Award, introduced by Davey Smith, MD, MAS |
|
12:50 pm |
Keynote Speaker, introduced by Sanjay Mehta, MD | |
1:00 pm |
Keynote Lecture: Integrated care models for key populations in India: Lessons learned |
Sunil Suhas Solomon, MBBS, PhD, MPH |
Session 3: Global Public Health: Mexico, moderated by Heather Pines, MPH, PhD | ||
2:20 pm |
Exploring labor exploitation and HIV/STI risk and infection among female migrants at the Mexico - Guatemala border |
Argentina Servin, MD, MPH |
2:40 pm |
Social and structural determinants of incident HIV infection among women who inject drugs in Tijuana, Mexico |
Jennifer Jain, MPH |
3:00 pm |
HIV incidence among men who have sex with men and transgender women in Tijuana, Mexico |
Britt Skaathun, PhD, MPH |
3:25 pm |
Costs and potential cost-savings for PrEP in a free transgender clinic in Tijuana, Mexico |
Jose Luis Burgos, MD, MPH |
3:45 pm | “If the virus scares us, our emotions will kill us”: A qualitative examination of how the LGBT community shapes HIV treatment experiences among gender and sexual minorities living with HIV in Tijuana Mexico | Laramie Smith, PhD |
4:05 pm |
Closing remarks | Davey Smith, MD, MAS |